Literature DB >> 2096411

Comparison of the effects of Alzheimer's disease, normal aging and scopolamine on human transient visual evoked potentials.

A T Smith1, F Early, G H Jones.   

Abstract

Transient visual evoked potentials elicited by the onset of a patterned stimulus were recorded in patients suffering from Alzheimer's disease (AD), in healthy elderly controls and in healthy young individual. The latencies and amplitudes of both the components studied were adversely affected by normal aging and one of the components, CI, but not the other, CII, showed further deterioration in AD. These changes occurred over a range of stimulus contrast levels. The changes found in AD, but not those seen in normal aging, could be mimicked by administration of the cholinergic antagonist scopolamine to young volunteers.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2096411     DOI: 10.1007/bf02247137

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  36 in total

1.  Amplitudes of visually evoked potentials to patterned stimuli: age and sex comparisons.

Authors:  J A La Marche; W R Dobson; N B Cohn; R E Dustman
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1986-03

2.  Changes in the human visual evoked potential caused by the anticholinergic agent hyoscine hydrobromide: comparison with results in Alzheimer's disease.

Authors:  A A Bajalan; C E Wright; V J van der Vliet
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-02       Impact factor: 10.154

3.  Developmental and aging changes in somatosensory, auditory and visual evoked potentials.

Authors:  T Allison; A L Hume; C C Wood; W R Goff
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1984-07

4.  Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey.

Authors:  M M Mesulam; E J Mufson; A I Levey; B H Wainer
Journal:  J Comp Neurol       Date:  1983-02-20       Impact factor: 3.215

5.  Pattern-evoked potentials and Bloch's law.

Authors:  M J Musselwhite; D A Jeffreys
Journal:  Vision Res       Date:  1982       Impact factor: 1.886

6.  A functional role of cholinergic innervation to neurons in the cat visual cortex.

Authors:  H Sato; Y Hata; H Masui; T Tsumoto
Journal:  J Neurophysiol       Date:  1987-10       Impact factor: 2.714

7.  Patterns of memory failure after scopolamine treatment: implications for cholinergic hypotheses of dementia.

Authors:  W W Beatty; N Butters; D S Janowsky
Journal:  Behav Neural Biol       Date:  1986-03

8.  Effects of oral scopolamine on human stimulus evaluation.

Authors:  E Callaway; R Halliday; H Naylor; G Schechter
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

9.  Modelling dementia: effects of scopolamine on memory and attention.

Authors:  P Broks; G C Preston; M Traub; P Poppleton; C Ward; S M Stahl
Journal:  Neuropsychologia       Date:  1988       Impact factor: 3.139

10.  Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques.

Authors:  R Katzman; R Terry; R DeTeresa; T Brown; P Davies; P Fuld; X Renbing; A Peck
Journal:  Ann Neurol       Date:  1988-02       Impact factor: 10.422

View more
  4 in total

1.  RU 41,656 does not reverse the scopolamine-induced cognitive deficit in healthy volunteers.

Authors:  A Patat; M J Klein; A Surjus; M Hucher; J Granier
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Anxiety disorders in non-demented and demented elderly patients: prevalence and correlates.

Authors:  Y Forsell; B Winblad
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-03       Impact factor: 10.154

3.  The metabolic brain pattern of young subjects given scopolamine.

Authors:  R M Cohen; M Gross; W E Semple; T E Nordahl; T Sunderland
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

4.  Visual evoked potentials to flash and pattern reversal stimulation after administration of systemic or topical scopolamine.

Authors:  G F Harding; R Daniels; S Panchal; N Drasdo; S J Anderson
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.